Congenital leukemia is a rare but well-documented disease in which a l
eukemic process is detected at birth or very shortly thereafter, An es
timated 175-200 reports of congenital leukemia have appeared in the li
terature. The majority of the cases reported have not undergone thorou
gh immunophenotyping, but rather have been assigned lineage based on c
ytochemical and morphological studies. Historically, a large proportio
n of congenital leukemias have been thought to be of the myeloid linea
ge, in contrast to pediatric leukemias in general, which are primarily
lymphoid. The precise proportions of the lineage assignments may be d
istorted by the inclusion of cases of transient myeloproliferative dis
orders (TMD) as congenital leukemia. The immunophenotyping data availa
ble to date suggest that congenital leukemias are phenotypically heter
ogeneous, lacking any common distinguishing markers, The prognosis for
congenital leukemias is usually poor if leukemoid reactive processes,
such as TMD, are carefully excluded. (C) 1995 Wiley-Liss, Inc.